(Date:5/22/2008)... in progression of risk factors as subjects aged ,...New insights into lung disease and lung function i..., The researchers analyzed data from the U.S. Nat...oronary Artery Risk Development in Young Adults) o...ears of health assessments in more than 5,000 youn...
(Date:5/22/2008)...illion Americans whove received drug-eluting stent...right future, according to new research from the U...The findings, among the first large follow-up stud...uting stents compared to bare metal stents, will b...the American College of Cardiology. Patients with ...
(Date:5/22/2008)...ozed at wheel; National Road Safety Fou...W YORK, May 22 /PRNewswire/ -- As people jam the r...hich marks the start of the peak summer,driving se...into -- a,drowsy driver, says the National Road Sa...vides free driver safety films and programs includ...
(Date:5/22/2008)...ewswire/ -- Many baby boomers,incorrectly believe ...to a,new survey conducted by Harris Interactive(R)...IP). Most say that disability insurance is importa...ey do not have any disability,income protection., ...830/AHIPLOGO ), "Baby boomers recognize the valu...
Breaking Medicine News(10 mins):Health News:CARDIA Studies Open Window on Heart, Lung Diseases 2Health News:CARDIA Studies Open Window on Heart, Lung Diseases 3Health News:More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures 2Health News:Drowsy Driving as Dangerous as Drunk Driving 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3...ernational research consortium investigating the g...s has identified a new genetic risk factor for coe...fering from coeliac disease lack a protective DNA ...n, otherwise found in healthy individuals. Behind...
...ing to a research abstract that will be presented ...sorder among infants and toddlers born prematurel... and at higher rates than among full-term infants....ontgomery-Downs, PhD, of West Virginia University,...
...orts are to be believed, then the "medical conditi...jail early, only to be thrown back inside a day l...ed infection. According to the News of the World ...I, and it is such a "severe problem" that Sheriff ...
...ocumented first -of -its-kind case, a teenager die...he aching muscles. Arielle Newman, 17, from Stat... surprisingly high amount of methyl salicylate, th...eams, was discovered in her body. Various compan...
Other Medicine News:Health News:Genetic Risk Factor for Coeliac Disease Identified. 2Health News:Paris' 'medical Condition' is a Sexually Transmitted Infection 2Health News:American Sports Star Teenager Dies Due To Overdose Of Muscle Cream 2(Date:5/22/2008)...didate, RDEA806, Demonstrated No Reproductive Toxi... -, - RDEA427 Selected as Clinical Candidate, Demo...ential for Once Daily Oral Dosing -, SAN DIEGO, M... Inc.,(Nasdaq: RDEA ) today announced preclinical...tase inhibitor (NNRTI) candidate, RDEA806, demonst...
(Date:5/21/2008)...derscore the Utility of CAPHOSOL in Treating Oral ...- New data show that CAPHOSOL(R), (http://www.caph...eves painful oral,mucositis (OM) and improves qual...erapy and radiation therapy. These data were repor... 33rd Annual Congress of the,Oncology Nursing Soci...
(Date:5/21/2008)...nted at 12th World Congress on the Menopause show ...yspareunia, two of the most frequent s... ARBOR, Mich., May 21 /- QuatRx Pharm...rom a pivotal Phase 3 study of Ophena(TM),(ospemif...mptoms of,vulvovaginal atrophy, a common condition...
(Date:5/21/2008)...EIGHTS, N.J., May 21 /- Gen...ed that multiple abstracts,featuring its lead onco...meeting of the American Society of Clinical Oncolo...he abstracts include the following:, -- Initial ... G4544, an oral gallium-containing Compound. ...
Breaking Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 2CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 3CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 5CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 6QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 1QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 3Hookah Smoking as Tough on Lungs as Cigarettes 9019 1Hookah Smoking as Tough on Lungs as Cigarettes 9019 2Hookah Smoking as Tough on Lungs as Cigarettes 9019 3Novel anticancer strategy moves from laboratory to clinic 9014 1Novel anticancer strategy moves from laboratory to clinic 9014 2Novel anticancer strategy moves from laboratory to clinic 9014 3...C -, EDMONTON, March 27 /CNW/ - Isotechnika Inc....ring committee (DMC) has met and reviewed,the in...OMISE),trial. The review included 3 month data f...ients to be enrolled. The DMC has,recommended th...udy,design. There were no concerns in this revie...
...ous Antihypertensives,to Date Presented at ACC Sci...ewswire-FirstCall/ -- Findings,from ECLIPSE**, the...hypertensive therapies, show that improved control...rmful elevation in,blood pressure just before, dur...g cardiac surgery is strongly associated with a,re...
Other Medicine Technology:Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 2Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 3Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 4Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 2Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 4Volk's super series slit lamp biomicroscopy lenses. General retinal scanning situations. Provide unprecedented fundus diagnostic capability, specifically addressing maximum potential field of view, f
Volk indirect lenses. High magnification views of the posterior pole.
Precision has its new line of programmable autoclaves which are easy to use bench-top autoclaves or models to fit any need. It has 4 adjustable sterilization programs, touch button control panel, man
...ina Tomograph is a confocal laser scanning microsc...nal images of the posterior segment. It enables th...y and precise follow-up of topographic changes. Th...eidelberg Retina Tomograph is the topographic desc...
Medicine Products: